FDA Inspection 585522 — ChiRhoClin, Inc
The FDA completed an inspection of ChiRhoClin, Inc on May 26, 2009 in Burtonsville, MD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 26, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Burtonsville, MD (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)